Site 590: Persahabatan Hospital
Jakarta, DKI Jakarta, Indonesia
Government hospital in East Jakarta
16, Jl. Persahabatan Raya No.1, RT.16/RW.13, Rawamangun, Kec. Pulo Gadung, Kota Jakarta Timur, Daerah Khusus Ibukota Jakarta 13230
About Site 590: Persahabatan Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Site 590: Persahabatan Hospital
During the past decade, Site 590: Persahabatan Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
2017-03-23
2022-07-27
Terminated
10,544
Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke
2019-06-11
2025-07-26
Active, not recruiting
12,301
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
2020-10-20
2025-06-25
Recruiting
678
A Cross-sectional Study of Lipoprotein(a) Levels in Patients With Documented History of Atherosclerotic Cardiovascular Disease (ASCVD)
2022-04-19
2024-01-05
Recruiting
40,000
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Site 590: Persahabatan Hospital"
#1 collaborator was "Abogen Biosciences Co. Ltd." with 1 trials as a collaborator, "CIMAB (Cuba)" with 1 trials as a collaborator, "Eurofarma Laboratorios S.A." with 1 trials as a collaborator, "Innogene Kalbiotech Pte. Ltd" with 1 trials as a collaborator and "Laboratorio Elea Phoenix S.A." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Site 590: Persahabatan Hospital
According to Clinical.Site data, the most researched conditions in "Site 590: Persahabatan Hospital" are
"COVID-19" (2 trials), "HIV" (1 trials), "Infectious Disease" (1 trials), "Lung Cancer, Non-small Cell" (1 trials) and "Lung Tuberculosis" (1 trials). Many other conditions were trialed in "Site 590: Persahabatan Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Site 590: Persahabatan Hospital
Most popular intervention types in "Site 590: Persahabatan Hospital" are "Biological" (3 trials) and "Other" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "ABO-CoV.617.2" (1 trials), "ABO1009-DP" (1 trials), "Best Support Treatment" (1 trials) and "No Intervention" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Site 590: Persahabatan Hospital
The vast majority of trials in "Site 590: Persahabatan Hospital" are
6 trials for "All" genders.
Clinical Trials Status at Site 590: Persahabatan Hospital
Currently, there are NaN active trials in "Site 590: Persahabatan Hospital".
undefined are not yet recruiting,
2 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Site 590: Persahabatan Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Site 590: Persahabatan Hospital, 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".